Benzodiazepines on trial: A research strategy for their rehabilitation

Trends in Pharmacological Sciences

Volumn 17, Issue 5, 1996, Pages 192-200

  Costa, Erminio ^a   Guidotti, Alessandro ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(10 CHLORO 4 OXO 3 PHENYL 4H BENZO(A) QUINOLIZIN 1 YL)CARBONYL] 2 PYRRODINEMETHANOL; 2 (4 CHLOROPHENYL) 5,6 DIHYDRO [1]BENZOTHIEPINO[5,4 C]PYRIDAZIN 3(2H) ONE 7 OXIDE; 2 (4 CHLOROPHENYL) 5,6 DIHYDRO [1]BENZOTHIEPINO[5,4C]PYRIDAZIN 3(2H) ONE 7 OXIDE; 2,3,5,6,7,8,9,10 OCTAHYDRO 2 (4 METHOXYPHENYL)CYCLOHEPTA[B]PYRAZOLO[3,4 D]PYRIDIN 3 ONE; 3 METHYL 6 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ABECARNIL; ALPIDEM; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BICUCULLINE; BRETAZENIL; CHLORIDE CHANNEL; CHLORIDE ION; CLONAZEPAM; DIAZEPAM; DIVAPLON; IMIDAZENIL; RO 198022; TRIAZOLAM; UNCLASSIFIED DRUG; ZOLPIDEM; ZOPICLONE;

ALLOSTERISM; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ATAXIA; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

EID: 0029884812     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)10015-8     Document Type: Review

References (50)

1. Costa, E., Guidotti, A. and Mao, C. C. (1975) Adv. Biochem. Psychopharmacol. 14, 113-130
2. Haefely, W. et al. (1975) Adv. Biochem. Psychopharmacol. 14, 131-151
3. Wisden, W. and Seeburg, P. H. (1992) Curr. Opin. Neurobiol. 2, 263-269
4. Macdonald, R. L. and Olsen, R. W. (1994) Annu. Rev. Neurosci. 17, 569-602
5. Barnard, E. A. (1995) Adv. Biochem. Psychopharmacol. 48, 1-16
6. Wisden, W., Laurie, D. J., Monyer, H. and Seeburg, P. H. (1992) J. Neurosci. 12, 1040-1062
7. Harris, B. T., Charlton, M. E., Costa, E. and Grayson, D. R. (1994) Mol. Pharmacol. 45, 637-648
8. Bovolin, P., Santi, M. R., Memo, M., Costa, E. and Grayson, D. R. (1992) J. Neurochem. 59, 62-67
9. Fritschy, J. M., Paysan, J., Enna, A. and Mohler, H. (1994) J. Neurosci. 14, 5302-5324
10. Zheng, T., Santi, M. R., Bovolin, P., Marlier, L. N. and Grayson, D. R. (1993) Dev. Brain Res. 75, 91-103
11. Primus, R. J. and Gallager, D. W. (1992) Eur. J. Pharmacol. - Mol. Pharmacol. Sect. 226, 21-28
12. Kang, I. and Miller, L. G. (1991) Br. J. Pharmacol. 103, 1285-1287
13. Zhao, T. J., Chiu, T. H. and Rosenberg, H. C. (1994) Mol. Pharmacol. 45, 657-663
14. Impagnatiello, F. et al. (1996) Mol. Pharmacol. 49, 832-841
15. Haefely, W. E. (1994) in The Challenge of Neuropharmacology (Mohler, H. and DaPrada, M., eds), pp. 15-36 Roche Basel, Switzerland
16. Ducic, I., Puia, G., Vicini, S. and Costa, E. (1993) Eur. J. Pharmacol. 244, 29-35
17. Lader, M. (1995) Adv. Biochem. Pharmacol. 48, 135-152
18. Mountcastle, V. B. (1957) J. Neurophysiol. 20, 408-434
19. Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O. and Somogyi, P. (1995) Nature 378, 75-78
20. Sillito, A. M. (1984) in Cerebral Cortex: Functional Properties of Cortical Cells (Jones, E. G. and Peters, A., eds), pp. 91-117, Plenum Press, New York
21. Farinas, I. and DeFelipe, J. (1991) J. Comp. Neurol. 304, 70-77
22. Sellal, F., Bacon, E. and Collard, M. (1994) Rev. Neurol. (Paris) 150, 330-337
23. Zheng, T. M. et al. (1994) Proc. Natl Acad. Sci. USA 91, 10952-10936
24. Farb, D. H. et al. (1989) Ann. NY Acad. Sci. 435, 1-31
25. Ducic, I., Caruncho, H. J., Zhu, W. J., Vicini, S. and Costa, E. (1995) J. Pharmacol. Exp. Ther. 272, 438-445
26. Puia, G., Vicini, S., Seeburg, P. H. and Costa, E. (1991) Mol. Pharmacol. 39, 691-696
27. Puia, G., Ducic, I., Vicini, S. and Costa, E. (1992) Proc. Natl Acad. Sci. USA 89, 3620-3624
28. Costa, E. et al. (1995) Adv. Biochem. Psychopharmacol. 48, 75-92
29. Korpi, E. R., Kleingoor, C., Kettenmann, H. and Seeburg, P. H. (1995) Nature 361, 356-359
30. Wieland, H. A., Luddens, H. and Seeburg, P. H. (1992) J. Biol. Chem. 267, 1426-1429
31. Sigel, E., Baur, R., Kellenberger, S. and Malherbe, P. (1992) EMBO J. 11, 2017-2023
32. Haefely, W., Martin, J. R. and Schoch, P. (1990) Trends Pharmacol. Sci. 11, 452-156
33. Auta, J., Giusti, P., Guidotti, A. and Costa, E. (1994) J. Pharmacol. Exp. Ther. 270, 1261-1269
34. Miller, L. G. et al. (1990) J. Pharmacol. Exp. Ther. 254, 33-38
35. Busto, U., Kaplan, H. L., Zawertailo, L. and Sellers, E. M. (1994) Clin. Pharmacol Ther. 55, 451-463
36. Auta, J. et al. (1995) Behav. Pharmacol. 6, 323-332
37. Giusti, P. et al. (1993) J. Pharmacol. Exp. Ther. 266, 1018-1028
38. Serra, M. et al. (1994) J. Pharmacol. Exp. Ther. 269, 32-38
39. Ghiani, C. A. et al. (1994) Eur. J. Pharmacol. 254, 299-302
40. Thompson, D. M., Auta, J., Guidotti, A. and Costa, E. (1995) J. Pharmacol. Exp. Ther. 273, 1307-1312
41. Giusti, P., Lipartiti, A., Zanotti, A. and Arban, A. (1993) Biochem. Pharmacol. 4, 459-460
42. Nutt, D. J. (1990) J. Psychiatr. Res. 24, 105-110
43. Jenck, F., Moreau, E. P., Bonetti, P., Martin, J. R. and Haefely, W. E. (1992) J. Pharmacol. Exp. Ther. 262, 1121-1127
44. Flackam, M. et al. (1992) J. Pharamcol. Exp. Ther. 261, 1113-1121
45. Knoflach, F., Drescher, U., Scheurer, L., Malherbe, P. and Mohler, H. (1993) J. Pharmacol. Exp. Ther. 266, 385-391
46. James, V. and Gardner, R. (1991) Drug. Dev. Res. 22, 331-337
47. Williams, M. et al. (1989) J. Pharmacol. Exp. Ther. 248, 89-96
48. Stephens, D. N. et al. (1990) J. Pharamcol. Exp. Ther. 253, 334-343
49. Yakushiji, T. et al. (1993) Br. J. Pharmacol. 109, 819-825
50. Yasumatsu, H. et al. (1994) Br. J. Pharmacol. 111, 1170-1178